These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8814476)
41. Cardiovascular and antiarrhythmic effects of esmolol in children. Trippel DL; Wiest DB; Gillette PC J Pediatr; 1991 Jul; 119(1 Pt 1):142-7. PubMed ID: 1676729 [TBL] [Abstract][Full Text] [Related]
42. Beta-blocker use in severe sepsis and septic shock: a systematic review. Sanfilippo F; Santonocito C; Morelli A; Foex P Curr Med Res Opin; 2015; 31(10):1817-25. PubMed ID: 26121122 [TBL] [Abstract][Full Text] [Related]
43. Effect of esmolol on fluid therapy in normovolemia and hypovolemia. Kinsky MP; Vaid SU; Vane LA; Prough DS; Kramer GC Shock; 2008 Jul; 30(1):55-63. PubMed ID: 18323741 [TBL] [Abstract][Full Text] [Related]
44. Use of esmolol to control autonomic instability of tetanus. King WW; Cave DR Am J Med; 1991 Oct; 91(4):425-8. PubMed ID: 1683152 [TBL] [Abstract][Full Text] [Related]
45. Role of beta-blockade in anaesthesia and postoperative pain management after hysterectomy. Chia YY; Chan MH; Ko NH; Liu K Br J Anaesth; 2004 Dec; 93(6):799-805. PubMed ID: 15377583 [TBL] [Abstract][Full Text] [Related]
46. Esmolol: a novel ultra-short acting beta-adrenoreceptor blocking agent. Singh BN; Laddu AR Ration Drug Ther; 1986 Aug; 20(8):1-7. PubMed ID: 2882545 [No Abstract] [Full Text] [Related]
47. Ultra-short-acting beta-adrenergic blockers. Frishman WH; Murthy S; Strom JA Med Clin North Am; 1988 Mar; 72(2):359-72. PubMed ID: 2894487 [TBL] [Abstract][Full Text] [Related]
49. Intravenous esmolol is well tolerated in elderly patients with heart failure in the early phase of non-ST elevation myocardial infarction. Koutouzis M; Nikolidakis S; Grigoriadis A; Koutsogeorgis D; Kyriakides ZS Drugs Aging; 2006; 23(8):673-80. PubMed ID: 16964989 [TBL] [Abstract][Full Text] [Related]
50. Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis. Gore DC; Wolfe RR Surgery; 2006 May; 139(5):686-94. PubMed ID: 16701103 [TBL] [Abstract][Full Text] [Related]
51. Effect of esmolol on oxidant status and antioxidant activity in acute myocardial infarction. Daga MK; Chaudhary M; Sharma B; Bhattacharjee J; Ghambhir DS; Arora N; Sudha R J Assoc Physicians India; 2003 Jul; 51():677-80. PubMed ID: 14621036 [TBL] [Abstract][Full Text] [Related]
52. Cardiac arrest after esmolol administration: a review of acute beta-blocker toxicity. Litman RS; Zerngast BA J Am Osteopath Assoc; 1996 Oct; 96(10):616-8. PubMed ID: 8936932 [TBL] [Abstract][Full Text] [Related]
53. Esmolol administration in patients with VV ECMO: why not? Pappalardo F; Zangrillo A; Pieri M; Landoni G; Morelli A; Stefani M; Guarracino F J Cardiothorac Vasc Anesth; 2013 Aug; 27(4):e40. PubMed ID: 23735468 [No Abstract] [Full Text] [Related]
59. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease. Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH Br J Clin Pharmacol; 1986 Dec; 22(6):697-706. PubMed ID: 2882772 [TBL] [Abstract][Full Text] [Related]
60. Postoperative beneficial effects of esmolol in treated hypertensive patients undergoing laparoscopic cholecystectomy. Ozturk T; Kaya H; Aran G; Aksun M; Savaci S Br J Anaesth; 2008 Feb; 100(2):211-4. PubMed ID: 18037672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]